19-9810937-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017703.3(FBXL12):c.940G>A(p.Val314Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,600,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017703.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL12 | NM_017703.3 | c.940G>A | p.Val314Ile | missense_variant | 3/3 | ENST00000247977.9 | NP_060173.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL12 | ENST00000247977.9 | c.940G>A | p.Val314Ile | missense_variant | 3/3 | 1 | NM_017703.3 | ENSP00000247977 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000148 AC: 37AN: 249788Hom.: 0 AF XY: 0.000163 AC XY: 22AN XY: 135044
GnomAD4 exome AF: 0.000131 AC: 190AN: 1448804Hom.: 0 Cov.: 30 AF XY: 0.000118 AC XY: 85AN XY: 717718
GnomAD4 genome AF: 0.000118 AC: 18AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2023 | The c.940G>A (p.V314I) alteration is located in exon 3 (coding exon 3) of the FBXL12 gene. This alteration results from a G to A substitution at nucleotide position 940, causing the valine (V) at amino acid position 314 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at